Zurn Water Solutions Corporation
Zurn Water Solutions Corporation (RXN) Stock Competitors & Peer Comparison
See (RXN) competitors and their performances in Stock Market.
Peer Comparison Table: Regulated Water Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RXN | $64.95 | +0.90% | 11.4B | N/A | N/A | +0.54% |
| AWK | $139.12 | -0.41% | 27.2B | 24.45 | $5.69 | +2.38% |
| SBS | $27.84 | +2.03% | 19.5B | 14.13 | $1.97 | +4.08% |
| WTRG | $41.04 | -1.46% | 11.6B | 18.66 | $2.20 | +3.30% |
| AWR | $75.30 | -0.41% | 2.9B | 22.35 | $3.37 | +2.63% |
| CWT | $45.03 | -0.38% | 2.7B | 20.94 | $2.15 | +2.74% |
| HTO | $58.68 | -0.42% | 2.1B | 20.10 | $2.92 | +2.90% |
| SJW | $54.86 | -0.67% | 1.9B | 18.29 | $3.00 | +0.77% |
| CDZIP | $19.34 | +1.19% | 1.5B | -23.19 | -$0.83 | N/A |
| WTTR | $14.16 | +1.07% | 1.5B | 67.48 | $0.21 | +1.97% |
Stock Comparison
RXN vs AWK Comparison March 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, AWK has a market cap of 27.2B. Regarding current trading prices, RXN is priced at $64.95, while AWK trades at $139.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas AWK's P/E ratio is 24.45. In terms of profitability, RXN's ROE is +0.13%, compared to AWK's ROE of +0.10%. Regarding short-term risk, RXN is more volatile compared to AWK. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check AWK's competition here
RXN vs SBS Comparison March 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, SBS has a market cap of 19.5B. Regarding current trading prices, RXN is priced at $64.95, while SBS trades at $27.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas SBS's P/E ratio is 14.13. In terms of profitability, RXN's ROE is +0.13%, compared to SBS's ROE of +0.20%. Regarding short-term risk, RXN is more volatile compared to SBS. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check SBS's competition here
RXN vs WTRG Comparison March 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, WTRG has a market cap of 11.6B. Regarding current trading prices, RXN is priced at $64.95, while WTRG trades at $41.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas WTRG's P/E ratio is 18.66. In terms of profitability, RXN's ROE is +0.13%, compared to WTRG's ROE of +0.09%. Regarding short-term risk, RXN is less volatile compared to WTRG. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check WTRG's competition here
RXN vs AWR Comparison March 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, AWR has a market cap of 2.9B. Regarding current trading prices, RXN is priced at $64.95, while AWR trades at $75.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas AWR's P/E ratio is 22.35. In terms of profitability, RXN's ROE is +0.13%, compared to AWR's ROE of +0.13%. Regarding short-term risk, RXN is more volatile compared to AWR. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check AWR's competition here
RXN vs CWT Comparison March 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, CWT has a market cap of 2.7B. Regarding current trading prices, RXN is priced at $64.95, while CWT trades at $45.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas CWT's P/E ratio is 20.94. In terms of profitability, RXN's ROE is +0.13%, compared to CWT's ROE of +0.08%. Regarding short-term risk, RXN is more volatile compared to CWT. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check CWT's competition here
RXN vs HTO Comparison March 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, HTO has a market cap of 2.1B. Regarding current trading prices, RXN is priced at $64.95, while HTO trades at $58.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas HTO's P/E ratio is 20.10. In terms of profitability, RXN's ROE is +0.13%, compared to HTO's ROE of +0.07%. Regarding short-term risk, RXN is more volatile compared to HTO. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check HTO's competition here
RXN vs SJW Comparison March 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, SJW has a market cap of 1.9B. Regarding current trading prices, RXN is priced at $64.95, while SJW trades at $54.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas SJW's P/E ratio is 18.29. In terms of profitability, RXN's ROE is +0.13%, compared to SJW's ROE of +0.07%. Regarding short-term risk, RXN is less volatile compared to SJW. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check SJW's competition here
RXN vs CDZIP Comparison March 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, CDZIP has a market cap of 1.5B. Regarding current trading prices, RXN is priced at $64.95, while CDZIP trades at $19.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas CDZIP's P/E ratio is -23.19. In terms of profitability, RXN's ROE is +0.13%, compared to CDZIP's ROE of -0.93%. Regarding short-term risk, RXN is more volatile compared to CDZIP. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check CDZIP's competition here
RXN vs WTTR Comparison March 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, WTTR has a market cap of 1.5B. Regarding current trading prices, RXN is priced at $64.95, while WTTR trades at $14.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas WTTR's P/E ratio is 67.48. In terms of profitability, RXN's ROE is +0.13%, compared to WTTR's ROE of +0.03%. Regarding short-term risk, RXN is less volatile compared to WTTR. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check WTTR's competition here
RXN vs MSEX Comparison March 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, MSEX has a market cap of 963.3M. Regarding current trading prices, RXN is priced at $64.95, while MSEX trades at $52.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas MSEX's P/E ratio is 22.04. In terms of profitability, RXN's ROE is +0.13%, compared to MSEX's ROE of +0.09%. Regarding short-term risk, RXN is less volatile compared to MSEX. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check MSEX's competition here
RXN vs CWCO Comparison March 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, CWCO has a market cap of 551.2M. Regarding current trading prices, RXN is priced at $64.95, while CWCO trades at $34.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas CWCO's P/E ratio is 32.04. In terms of profitability, RXN's ROE is +0.13%, compared to CWCO's ROE of +0.08%. Regarding short-term risk, RXN is less volatile compared to CWCO. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check CWCO's competition here
RXN vs YORW Comparison March 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, YORW has a market cap of 455.9M. Regarding current trading prices, RXN is priced at $64.95, while YORW trades at $31.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas YORW's P/E ratio is 22.70. In terms of profitability, RXN's ROE is +0.13%, compared to YORW's ROE of +0.08%. Regarding short-term risk, RXN is less volatile compared to YORW. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check YORW's competition here
RXN vs CDZI Comparison March 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, CDZI has a market cap of 433.2M. Regarding current trading prices, RXN is priced at $64.95, while CDZI trades at $5.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas CDZI's P/E ratio is -10.53. In terms of profitability, RXN's ROE is +0.13%, compared to CDZI's ROE of -0.93%. Regarding short-term risk, RXN is less volatile compared to CDZI. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check CDZI's competition here
RXN vs ARTNA Comparison March 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, ARTNA has a market cap of 330.1M. Regarding current trading prices, RXN is priced at $64.95, while ARTNA trades at $31.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas ARTNA's P/E ratio is 14.65. In terms of profitability, RXN's ROE is +0.13%, compared to ARTNA's ROE of +0.09%. Regarding short-term risk, RXN is less volatile compared to ARTNA. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check ARTNA's competition here
RXN vs VWTR Comparison March 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, VWTR has a market cap of 288.2M. Regarding current trading prices, RXN is priced at $64.95, while VWTR trades at $15.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas VWTR's P/E ratio is 9.29. In terms of profitability, RXN's ROE is +0.13%, compared to VWTR's ROE of +0.17%. Regarding short-term risk, RXN is more volatile compared to VWTR. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check VWTR's competition here
RXN vs PCYO Comparison March 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, PCYO has a market cap of 250.1M. Regarding current trading prices, RXN is priced at $64.95, while PCYO trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas PCYO's P/E ratio is 18.21. In terms of profitability, RXN's ROE is +0.13%, compared to PCYO's ROE of +0.10%. Regarding short-term risk, RXN is more volatile compared to PCYO. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check PCYO's competition here
RXN vs GWRS Comparison March 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, GWRS has a market cap of 216.8M. Regarding current trading prices, RXN is priced at $64.95, while GWRS trades at $7.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas GWRS's P/E ratio is 68.55. In terms of profitability, RXN's ROE is +0.13%, compared to GWRS's ROE of +0.04%. Regarding short-term risk, RXN is less volatile compared to GWRS. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check GWRS's competition here